학술논문
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
Document Type
Journal
Author
Stuart, Arabella S., V; Shaw, Robert H.; Liu, Xinxue; Greenland, Melanie; Aley, Parvinder K.; Andrews, Nick J.; Cameron, J. C.; Charlton, Sue; Clutterbuck, Elizabeth A.; Collins, Andrea M.; Darton, Tom; Dinesh, Tanya; Duncan, Christopher J. A.; England, Anna; Faust, Saul N.; Ferreira, Daniela M.; Finn, Adam; Goodman, Anna L.; Green, Christopher A.; Hallis, Bassam; Heath, Paul T.; Hill, Helen; Horsington, Bryn M.; Lambe, Teresa; Lazarus, Rajeka; Libri, Vincenzo; Lillie, Patrick J.; Mujadidi, Yama F.; Payne, Ruth; Plested, Emma L.; Provstgaard-Morys, Samuel; Ramasamy, Maheshi N.; Ramsay, Mary; Read, Robert C.; Robinson, Hannah; Screaton, Gavin R.; Singh, Nisha; Turner, David P. J.; Turner, Paul J.; Vichos, Iason; White, Rachel; Nguyen-Van-Tam, Jonathan S.; Snape, Matthew D.; Com-COV2 Study Grp
Source
Subject
Language
English
ISSN
1474547X